Fairchem Organics Ltd AI Stock Analysis
Want to see IN:FAIRCHEMOR full AI Analyst Report?
Fairchem Organics Ltd (FAIRCHEMOR) AI Stock Analysis
Fairchem Organics Ltd
(NSE:FAIRCHEMOR)
The overall score of 50 reflects a sharp conflict between poor fundamentals and strong market momentum. The company's financial performance is severely weakened by declining revenues and collapsing margins, and its valuation is extremely high with a P/E over 71. These factors are significant risks. However, the stock's price is being driven higher by powerful bullish technical momentum, trading above all key moving averages with strong MACD and RSI readings. The final score is a weighted compromise, heavily pulled down by the weak financial base and stretched valuation, but lifted by the current technical strength.
Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 8.25B
- Dividend Yield
- 0.15%
- Average Volume (3M)
- 3,002
- Price to Earnings (P/E)
- 35.4
- Beta (1Y)
- 0.10
- Revenue Growth
- 17.44%
- EPS Growth
- 304.08%
- Country
- India
- Employees
- 212
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Fairchem Organics Ltd Business Overview & Revenue Model
Company Description
Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across India...
Fairchem Organics Ltd Financial Statement Overview
Summary
Financial health is under significant pressure. Revenue has declined for three consecutive years, gross margin collapsed to 7.7%, and net margin is a thin 1.2%. While the balance sheet has moderate leverage (D/E 0.32), return on equity is a very low 2.1%, and cash flow generation, though positive, is volatile and covers only 37% of total debt.
Income Statement
30NegativeBalance Sheet
40NegativeCash Flow
35Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.60B | 4.60B | 5.38B | 6.21B | 6.47B | 6.42B |
| Gross Profit | 642.92M | 355.37M | 666.52M | 1.54B | 1.56B | 1.78B |
| EBITDA | 446.72M | 220.40M | 441.21M | 681.10M | 729.68M | 1.05B |
| Net Income | 237.76M | 55.41M | 219.74M | 405.00M | 435.01M | 679.06M |
Balance Sheet | ||||||
| Total Assets | 3.98B | 3.91B | 4.02B | 3.34B | 3.42B | 3.24B |
| Cash, Cash Equivalents and Short-Term Investments | 14.24M | 12.26M | 12.86M | 84.00K | 838.00K | 83.00K |
| Total Debt | 702.35M | 837.82M | 630.32M | 73.18M | 501.68M | 620.30M |
| Total Liabilities | 1.17B | 1.28B | 997.98M | 443.77M | 831.48M | 919.26M |
| Stockholders Equity | 2.82B | 2.63B | 3.02B | 2.90B | 2.59B | 2.32B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 229.13M | -464.87M | 563.52M | 348.89M | 58.91M |
| Operating Cash Flow | 0 | 382.54M | -203.78M | 744.80M | 496.15M | 404.85M |
| Investing Cash Flow | 0 | -140.95M | -255.71M | -176.25M | -144.92M | -341.84M |
| Financing Cash Flow | 0 | -241.53M | 459.49M | -568.55M | -351.24M | -63.19M |
Fairchem Organics Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Negative. The current price of 662.15 is below the 20-day moving average (MA) of 687.36, below the 50-day MA of 681.98, and above the 200-day MA of 638.73, indicating a neutral trend. The MACD of -9.07 indicates Positive momentum. The RSI at 44.34 is Neutral, neither overbought nor oversold. The STOCH value of 33.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FAIRCHEMOR.
Fairchem Organics Ltd Peers Comparison
Overall Rating
IN:ALKYLAMINE70.6Outperform
IN:ATUL68Neutral
IN:JUBLINGREA53Neutral
IN:LXCHEM53Neutral
IN:FAIRCHEMOR50Neutral
IN:AARTIIND47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | INR 82.34B | 33.20 | ― | 0.62% | 13.38% | 35.82% | |
| 68Neutral | INR 149.64B | 19.38 | ― | 0.59% | 18.15% | 42.38% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | INR 93.80B | 26.49 | ― | 0.85% | 15.41% | 21.76% | |
| 53Neutral | INR 42.83B | 24.88 | ― | 0.19% | 21.34% | 105.39% | |
| 50Neutral | INR 8.34B | 35.38 | ― | 0.15% | 17.44% | 304.08% | |
| 47Neutral | INR 170.80B | 28.78 | ― | 0.21% | 39.85% | 103.71% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:FAIRCHEMOR | Fairchem Organics Ltd | 662.15 | -34.40 | -4.94% | |
| IN:AARTIIND | AARTI Industries Ltd | 470.85 | 81.37 | 20.89% | |
| IN:ALKYLAMINE | Alkyl Amines Chemicals Limited | 1609.75 | -151.46 | -8.60% | |
| IN:ATUL | Atul Limited | 5082.70 | -1021.02 | -16.73% | |
| IN:JUBLINGREA | Jubilant Ingrevia Ltd. | 588.90 | -119.43 | -16.86% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 154.10 | -28.24 | -15.49% |
Fairchem Organics Ltd Corporate Events
Fairchem Organics Confirms Full Demat Compliance Under SEBI Rules
Fairchem Organics Ltd has reported to the NSE and BSE that it has obtained the required confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The filing...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 14, 2026
